|
Report Date : |
31.08.2013 |
IDENTIFICATION DETAILS
|
Name : |
SCHAZOO ZAKA (PVT.) LIMITED |
|
|
|
|
Registered Office : |
Schazoo House, 45-G.T. Road, Lahore |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Financials (as on) : |
30.06.2010 |
|
|
|
|
Year of Incorporation : |
2005 |
|
|
|
|
Com. Reg. No.: |
0049408 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture &
Marketing of Pharmaceutical Products |
|
|
|
|
No. of Employees : |
112 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Pakistan |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
PAKISTAN - ECONOMIC OVERVIEW
Decades of internal political disputes and low levels of
foreign investment have led to slow growth and underdevelopment in Pakistan.
Agriculture accounts for more than one-fifth of output and two-fifths of
employment. Textiles account for most of Pakistan's export earnings, and
Pakistan's failure to expand a viable export base for other manufactures has
left the country vulnerable to shifts in world demand. Official unemployment is
under 6%, but this fails to capture the true picture, because much of the economy
is informal and underemployment remains high. Over the past few years, low
growth and high inflation, led by a spurt in food prices, have increased the
amount of poverty - the UN Human Development Report estimated poverty in 2011
at almost 50% of the population. Inflation has worsened the situation, climbing
from 7.7% in 2007 to almost 12% for 2011, before declining to 10% in 2012. As a
result of political and economic instability, the Pakistani rupee has
depreciated more than 40% since 2007. The government agreed to an International
Monetary Fund Standby Arrangement in November 2008 in response to a balance of
payments crisis. Although the economy has stabilized since the crisis, it has
failed to recover. Foreign investment has not returned, due to investor
concerns related to governance, energy, security, and a slow-down in the global
economy. Remittances from overseas workers, averaging about $1 billion a month
since March 2011, remain a bright spot for Pakistan. However, after a small
current account surplus in fiscal year 2011 (July 2010/June 2011), Pakistan's
current account turned to deficit in fiscal year 2012, spurred by higher prices
for imported oil and lower prices for exported cotton. Pakistan remains stuck
in a low-income, low-growth trap, with growth averaging about 3% per year from
2008 to 2012. Pakistan must address long standing issues related to government
revenues and energy production in order to spur the amount of economic growth
that will be necessary to employ its growing and rapidly urbanizing population,
more than half of which is under 22. Other long term challenges include
expanding investment in education and healthcare, adapting to the effects of
climate change and natural disasters, and reducing dependence on foreign donors.
Source
: CIA
SCHAZOO ZAKA (PVT.) LIMITED
Registered Address
|
|
Schazoo House, 45-G.T. Road, Lahore, Pakistan |
|
Tel # |
92 (42) 111-666-600, 36818450, 36856631 |
|
Fax # |
92 (42) 36841003 |
|
Email |
|
a. |
Nature of Business |
Manufacture
& Marketing of Pharmaceutical Products |
|
b. |
Year Established |
2005 |
|
c. |
Registration # |
0049408 |
Kalalwala,
20 K.M., Lahore-Jaranwala
Road,
District Sheikhupura,
Pakistan
|
A. Aziz Chaudhry & Co. (Chartered
Accountants) 38, Shahrah-e-Quaid-e-Azam, Lahore, Pakistan |
|
Subject Company was established as a Private Limited Company in 2005 |
|
6. |
Authorized Capital |
Rs. 70,000,000/- divided into 7,000,000
shares of Rs. 10/- each |
|
|
Issued & Paid up Capital |
Rs. 50,588,000/- divided into 5,058,800
shares of Rs. 10/- each |
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Mohammed Zaka-Ur-Rehman Mrs. Begum Almas Zaka-Ur-Rehman Mr. Ahmad Zaka-Ur-Rehman Mrs. Aasia Saail Khan Mrs. Zeba Ahmad Shuja Mrs. Samira Shahzad |
Pakistani Pakistani Pakistani Pakistani Pakistani Pakistani |
Schazoo House,
45-G.T. Road, Lahore Schazoo House,
45-G.T. Road, Lahore Schazoo House, 45-G.T.
Road, Lahore Schazoo House,
45-G.T. Road, Lahore Schazoo House,
45-G.T. Road, Lahore Schazoo House,
45-G.T. Road, Lahore |
Business Business Business Business Business Business |
Chief Executive Director Director Director Director Director |
|
Names |
No. of Shares |
|
Mr. Mohammed Zaka-Ur-Rehman Mrs. Begum Almas Zaka-Ur-Rehman Mr. Ahmed Zaka-Ur-Rehman Mrs. Aasia Saail Khan Mrs. Zeba Ahmed Shuja Mrs. Samira Shahzad |
480,383 3,377,559 480,383 276,767 241,356 202,352 |
A. Subsidiary
None
B. Associated
Companies
(1) The Schazoo
Laboratories (Pvt) Limited, Pakistan.
(2) The Schazoo Pharmaceutical Laboratories,
Pakistan.
(3) Zaka Healthcare, Pakistan.
Manufacture &
Marketing of Pharmaceutical Products by its brand names of BONE-CARE,
CARTEX, CARTEX-H, CIPROL, CITRFAST, CYCLOSEN, DOGREL, ETHOMID, FIOFEN, HESTIN,
KOTIN, LEBRIN, LERBIN, LIPIDIN, LODIPIN, LOTENSE, LOTENSE-H, NASARIN, NEOBUTINAL,
NOPAIN, ORTHONATE, PAINCID, PERIMAC, PIOFIT, PIRODEX,
112
(1)
HARBIN
(2)
SHANGHAI SHAMROCK IMP & EXP CO., CHINA.
(3)
ZHEJIANG
GUOBANG PHARMACEUTICAL CO. LTD, CHINA.
The capacity and
production of the company’s plant is indeterminable as it involves varying
processes of manufacture.
|
Year |
In Pak Rupees |
|
2010 |
377,221,029/- |
|
Mainly exist at major cities of Pakistan |
|
(1)
The Bank of Punjab, Pakistan. (2) Habib Metropolitan Bank Limited, Pakistan. (3) Faysal Bank Limited, Pakistan. (4) United Bank Limited, Pakistan. (5) Allied Bank Limited, Pakistan. (6) Bank Alfalah Limited, Pakistan. |
·
Lahore Chamber of Commerce & Industry. (
·
Pakistan Pharmaceutical Manufacturers Association.(PPMA)
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 104.00 |
|
UK Pound |
1 |
Rs. 161.00 |
|
Euro |
1 |
Rs. 138.25 |
Subject Company was established in 2005 and
is engaged in manufacture & marketing of Pharmaceutical Products. Overall
reputation is satisfactory. Trade relations are reported as fair. Subject can
be considered for normal business dealings at usual trade terms &
conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.57 |
|
|
1 |
Rs.103.34 |
|
Euro |
1 |
Rs.88.16 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.